Large calibre arterial access device closure for percutaneous aortic valve interventions: Use of the prostar system in 118 cases

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 1, 2012, Pages 143-149

  Cockburn, James ^a   De Belder, Adam ^a   Brooks, Michael ^a   Hutchinson, Nevil ^a   Hill, Andrew ^a   Trivedi, Uday ^a   Hildick Smith, David ^a  

^a UK   (United Kingdom)

Author keywords

aortic stenosis; arterial access; balloon aortic valvuloplasty; prostar; transcatheter aortic valve implantation

Indexed keywords

AGE; AGED; AORTA STENOSIS; AORTIC VALVE REPAIR; ARTICLE; CONTROLLED STUDY; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; SEX RATIO; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE; WOUND CLOSURE;

EID: 83655174186     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23105     Document Type: Article

References (25)

1. Lung B, Baron G, Butchart EG,. A prospective survey of patients with valvular heart disease in Europe: The Euro heart survey on valvular heart disease. Eur Heart J 2003; 24: 1231-1243. (Pubitemid 36834640)
2. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-e231. (Pubitemid 44268973)
3. Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B,. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: An alternative to valve replacement? Lancet 1986; 1: 63-67.
4. Roques F, Michel P, Goldstone AR, Nashef SA,. The logistic EuroSCORE. Eur heart J 2003; 24: 882-883.
5. Serruys PW, Luijten HE, Beatt KJ, et al. Percutaneous balloon valvuloplasty for calcific aortic stenosis. A treatment 'sine cure'? Eur Heart J 1988; 9: 782-794.
6. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V,. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol 2006; 47: 1214-1223.
7. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006; 114: 1616-1624. (Pubitemid 44547432)
8. Haas CP, Krajcer Z, Diethrich E,. Closure of large percutaneous access sites using the prostar XL percutaneous vascular surgery device. J Endovasc Surg 1999; 6: 168-170. (Pubitemid 29296195)
9. Cattelaens N, Gerkens U, Muller R, Staberock M, Grzan O, Lampe EG, Simpson JB, Grube E,. The prostar plus percutaneous closure device vs manual compression following coronary interventions. Circulation 1996; 94: 1-484.
10. Van Mieghem NM, Nuis RJ, Piazza N, et al. Vascular complications with transcatheter aortic valve implantation using the 18F Medtronic CoreValve system: The Rotterdam experience. Eurointervention 2010; 5: 673-679.
11. Chew DP, Bhatt DL, Lincoff AM,. Clinical endpoint definitions following percutaneous coronary intervention and their relationship to late mortality: An assessment by attributable risk. Heart 2006; 92: 945-950. (Pubitemid 43974059)
12. Kussmaul WG, Buchbinder M, Whitlow PL,. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: Result of a randomized trial of a novel hemostatic device. J Am Coll Cardiol 1995; 25: 1685-1692.
13. Gerckens U, Cattelaens N, Muller R, Staberock M, Grzan O, Lampe EG, Simpson JB, Grube E,. Early ambulation following elective diagnostic coronary angioplasty using a percutaneous arterial closure device: A randomised trial vs manual compression. Circulation 1996; 94: 1-484.
14. Baim DS, Knopf WD, Hinohara T, Schwarten DE, Schatz RA, Pinkerton CA,. Subture mediated closure of the femoral access site after cardiac catheterization: Results of the subtures to ambulate aNd discharge (STAND I and II) trials. Am J Cardiol 2000; 85: 864-869. (Pubitemid 30157854)
15. Sesana M, Vaghetti M, Alberio R, Corvaja N, Martini G, Sivierei G,. Effectiveness and complications of vascular closure devices after interventional procedures. J Invasive Cardiol 2000; 12: 395-399.
16. Torsello GB, Kasprzak B, Klenk E,. Endovascular suture versus cutdown for endovascular aneurysm repair: A prospective randomized pilot study. J Vasc Surg 2003; 38: 78-82. (Pubitemid 41123291)
17. Howell M, Doughtery K, Strickman N,. Percutaneous repair of abdominal aortic aneurysms using the AneuRx stent graft and the percutaneous vascular surgery device. Catheter Cardiovasc Interv 2002; 55: 281-228.
18. Murray D, Ghosh J, Khwaja N, et al. Access for endovascular aneurysm repair. J Endovasc Ther 2006; 13: 754-761. (Pubitemid 44907639)
19. Jean-Baptiste E, Hassen-Khodja R, Haudebourg P,. Percutaneous closure devices for endovascular repair of infrarenal abdominal aortic aneurysms: A prospective, non-randomized comparative study. Eur J Vasc Endovasc Surg 2008; 35: 422-428. (Pubitemid 351296164)
20. Joseph PC, Richard EK, Marc JL,. Angiographic and clinical outcome of intracoronary stenting: Immediate and long-term results from a large, single-centre experience. J Am Coll Cardiol 1992; 20: 328-337.
21. Dick RJ, Popma JJ, Muller DW,. In-hospital costs associated with new percutaneous coronary device. Am J Cardiol 1991; 168: 879-885.
22. Krause PB, Klein LW,. Utility of a percutaneous collagen hemostasis device: To plug or not to plug? J Am Coll Cardiol 1991; 22: 1280-1282. (Pubitemid 23316346)
23. Moscucci M, Fox KAA, Cannon C, Klein W, Lopez-Sendon J, Montalescot K, Goldberg R,. Predictors of major bleeding in acute coronary syndromes: The global registry of acute coronary events (GRACE). Eur Heart J 2003; 24: 1815-1823. (Pubitemid 37280247)
24. Latsios G, Gerckens U, Grube E,. Tran aortic transcatheter aortic valve implantation: A novel approach for the truly "no-access option" patients. Catheter Cardiovasc Interv 2010; 75: 1129-1136.
25. Bauernschmitt R, Schreiber C, Bleiziffer S, et al. Transcatheter aortic valve implantation through the ascending aorta: An alternative option for no-access patients. Heart Surg Forum 2009; 12: E63-E64.